Evidence map›Paper›PMID 31782850›Full record

ArticleCell proliferation2020

SHP2 deficiency promotes Staphylococcus aureus pneumonia following influenza infection.

Wei Ouyang, Chao Liu, Ying Pan, Yu Han, Liping Yang, Jingyan Xia, Feng Xu

Abstract read
In one paragraph

Article in Cell proliferation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A comprehensive review of SHP2 and its role in cancer.Cellular oncology (Dordrecht, Netherlands) · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wei OuyangDepartment of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chao LiuDepartment of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ying PanDepartment of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Yu HanDepartment of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liping YangDepartment of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Jingyan XiaDepartment of Radiation Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Feng XuDepartment of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID https://orcid.org/0000-0001-5764-6628

Funding

National Natural Science Foundation of China 81570004National Natural Science Foundation of China 81570005National Natural Science Foundation of China 81770008
6 · The paper itself

Abstract

objectivesSecondary bacterial pneumonia is common following influenza infection. However, it remains unclear about the underlying molecular mechanisms. MATERIALS AND

methodsWe established a mouse model of post-influenza S aureus pneumonia using conditional Shp2 knockout mice (LysM

resultsLysM

conclusionsOur findings reveal that the SHP2 expression enhances the host immune response and prompts bacterial clearance in post-influenza S aureus pneumonia.

Indexed as

AnimalsInflammationInfluenza A virusInterferon Regulatory Factor-3MacrophagesMiceMice, TransgenicNF-kappa BOrthomyxoviridae InfectionsPneumonia, StaphylococcalProtein Tyrosine Phosphatase, Non-Receptor Type 11Staphylococcus aureusInterferon Regulatory Factor-3Irf3 protein, mouseNF-kappa BProtein Tyrosine Phosphatase, Non-Receptor Type 11Ptpn11 protein, mousechemo-attractantsinflammatory responsemacrophage polarizationprotein-tyrosine phosphatase SHP2secondary bacterial pneumoniatype I interferon

Identifiers

PMID31782850
PMCPMC6985656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.